SMART-ALD - A New Lifestyle Intervention to Improve Quality of Life in Women With X-linked Adrenoleukodystrophy (X-ALD)
SMART-ALD - A New Lifestyle Intervention to Improve Physical and Mental Well-being and Quality of Life in Women With X-linked Adrenoleukodystrophy (X-ALD)
Sponsor: European Leukodystrophy Association
Listed as NCT04687007, this NA trial focuses on X-linked Adrenoleukodystrophy and remains completed. Sponsored by European Leukodystrophy Association, it has been updated 12 times since 2022, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2024 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Apr 2023 — Apr 2024 [monthly]
Active Not Recruiting NA
▶ Show 7 earlier versions
-
Jan 2023 — Apr 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2022 — Jan 2023 [monthly]
Recruiting NA
-
Jun 2022 — Sep 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2022 — Jun 2022 [monthly]
Not Yet Recruiting NA
-
Feb 2022 — May 2022 [monthly]
Not Yet Recruiting NA
-
Oct 2021 — Feb 2022 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — Oct 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- European Leukodystrophy Association
- Leipzig University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .